Answers are grounded in this paper and cite their sources.
Objective: The aim of this study to evaluate the anti-depressant activity of ethanolic extract of Piper methysticum leaves in mice. Methods: The animals were grouped into four groups, each comprising 6 mice. One of the group as control, receiving normal saline water and second group as standard, receiving fluoxetine, while the remaining two groups were administered the test drug (300 mg/kg and 600 mg/kg). All drug administrations were conducted orally 1 h prior to the acute study test procedure and daily for a 14 d period for the chronic study. Results: The administration of Piper methysticum doses resulted in a notable reduction in immobility duration during the Tail Suspension Test. In the Actophotometer assessment, mice exhibited a statistically significant increase in motor activity compared to the control group. The findings indicated that the ethanolic extract of Piper methysticum leaves at a dose of 600 mg/kg led to a significant increase in reduced glutathione and catalase activity. Simultaneously, there was a decrease in plasma corticosterone, lipid peroxidation, plasma nitrite, and protein concentration levels. Conclusion: The antidepressant efficacy of Piper methysticum at a dosage of 600 mg/kg in mice is comparable to that of fluoxetine.
No takes yet. Share an insight, caveat, or question.
THAKUR et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: